Antti Hakanen

ORCID: 0000-0003-4180-0306
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Salmonella and Campylobacter epidemiology
  • Bacterial Identification and Susceptibility Testing
  • Urinary Tract Infections Management
  • Veterinary medicine and infectious diseases
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Use and Resistance
  • Viral gastroenteritis research and epidemiology
  • Genetic Associations and Epidemiology
  • Gut microbiota and health
  • Orthopedic Infections and Treatments
  • Pneumonia and Respiratory Infections
  • Vibrio bacteria research studies
  • Enterobacteriaceae and Cronobacter Research
  • Infective Endocarditis Diagnosis and Management
  • Intraperitoneal and Appendiceal Malignancies
  • Antibiotics Pharmacokinetics and Efficacy
  • Colorectal Cancer Screening and Detection
  • Appendicitis Diagnosis and Management
  • Escherichia coli research studies
  • Bacterial Infections and Vaccines
  • Chronic Disease Management Strategies
  • Respiratory viral infections research
  • BRCA gene mutations in cancer
  • Sleep and related disorders

University of Turku
2013-2025

Varsinais-Suomen Sairaanhoitopiiri
2021-2025

Turku University Hospital
2009-2024

Institute for Molecular Medicine Finland
2023

University of Helsinki
2023

Immunité et Cancer
2019

Finnish Institute for Health and Welfare
2009-2014

National Institutes of Health
2009-2012

CNR de la Résistance aux Antibiotiques
2009-2010

Public Health Institute
1999-2007

Mitja Kurki Juha Karjalainen Priit Palta Timo P. Sipilä Kati Kristiansson and 95 more Kati Donner Mary Pat Reeve Hannele Laivuori Mervi Aavikko Mari Kaunisto Anu Loukola Elisa Lahtela Hannele Mattsson Päivi Laiho Pietro Della Briotta Parolo Arto Lehistö Masahiro Kanai Nina Mars Joel Rämö Tuomo Kiiskinen Henrike Heyne Kumar Veerapen Sina Rüeger Susanna Lemmelä Wei Zhou Sanni Ruotsalainen Kalle Pärn Tero Hiekkalinna Sami Koskelainen Teemu Paajanen Vincent Llorens Javier Gracia‐Tabuenca Harri Siirtola Kadri Reis Abdelrahman G. Elnahas Benjamin B. Sun Christopher N. Foley Katriina Aalto‐Setälä Kaur Alasoo Mikko Arvas Kirsi Auro Shameek Biswas Argyro Bizaki-Vallaskangas Olli Carpén Chia‐Yen Chen Oluwaseun Alexander Dada Zhihao Ding Margaret G. Ehm Kari K. Eklund Martti Färkkilâ Hilary K. Finucane Andrea Ganna Awaisa Ghazal Robert Graham Eric M. Green Antti Hakanen Marco Hautalahti Åsa K. Hedman Mikko Hiltunen Reetta Hinttala Iiris Hovatta Xinli Hu Adriana Huertas‐Vázquez Laura Huilaja Julie Hunkapiller Howard Jacob Jan-Nygaard Jensen Heikki Joensuu Sally John Valtteri Julkunen Marc Jung Juhani Junttila Kai Kaarniranta Mika Kähönen Risto Kajanne Lila Kallio Reetta Kälviäinen Jaakko Kaprio Nurlan Kerimov Johannes Kettunen Elina Kilpeläinen Terhi Kilpi K. Klinger Veli‐Matti Kosma Teijo Kuopio Venla Kurra Triin Laisk Jari A. Laukkanen Nathan Lawless Aoxing Liu Simonne Longerich Reedik Mägi Johanna Mäkelä Antti Mäkitie Anders Mälarstig Graham J. Mann Joseph Maranville Athena Matakidou Tuomo J Meretoja Sahar V. Mozaffari

Abstract Population isolates such as those in Finland benefit genetic research because deleterious alleles are often concentrated on a small number of low-frequency variants (0.1% ≤ minor allele frequency < 5%). These survived the founding bottleneck rather than being distributed over large ultrarare variants. Although this effect is well established Mendelian genetics, its value common disease genetics less explored 1,2 . FinnGen aims to study genome and national health register data...

10.1038/s41586-022-05473-8 article EN cc-by Nature 2023-01-18
Mitja Kurki Juha Karjalainen Priit Palta Timo P. Sipilä Kati Kristiansson and 95 more Kati Donner Mary Pat Reeve Hannele Laivuori Mervi Aavikko Mari Kaunisto Anu Loukola Elisa Lahtela Hannele Mattsson Päivi Laiho Pietro Della Briotta Parolo Arto Lehistö Masahiro Kanai Nina Mars Joel Rämö Tuomo Kiiskinen Henrike Heyne Kumar Veerapen Sina Rüeger Susanna Lemmelä Wei Zhou Sanni Ruotsalainen Kalle Pärn Tero Hiekkalinna Sami Koskelainen Teemu Paajanen Vincent Llorens Javier Gracia‐Tabuenca Harri Siirtola Kadri Reis Abdelrahman G. Elnahas Katriina Aalto‐Setälä Kaur Alasoo Mikko Arvas Kirsi Auro Shameek Biswas Argyro Bizaki-Vallaskangas Olli Carpén Chia‐Yen Chen Oluwaseun Alexander Dada Zhihao Ding Margaret G. Ehm Kari K. Eklund Martti Färkkilâ Hilary K. Finucane Andrea Ganna Awaisa Ghazal Robert Graham Eric Green Antti Hakanen Marco Hautalahti Åsa K. Hedman Mikko Hiltunen Reetta Hinttala Iiris Hovatta Xinli Hu Adriana Huertas‐Vázquez Laura Huilaja Julie Hunkapiller Howard J. Jacob Jan-Nygaard Jensen Heikki Joensuu Sally John Valtteri Julkunen Marc Jung Juhani Junttila Kai Kaarniranta Mika Kähönen Risto Kajanne Lila Kallio Reetta Kälviäinen Jaakko Kaprio Nurlan Kerimov Johannes Kettunen Elina Kilpeläinen Terhi Kilpi K. Klinger Veli‐Matti Kosma Teijo Kuopio Venla Kurra Triin Laisk Jari A. Laukkanen Nathan Lawless Aoxing Liu Simonne Longerich Reedik Mägi Johanna Mäkelä Antti Mäkitie Anders Mälarstig Arto Mannermaa Joseph Maranville Athena Matakidou Tuomo J Meretoja Sahar V. Mozaffari Mari Niemi Marianna Niemi

ABSTRACT Population isolates such as Finland provide benefits in genetic studies because the allelic spectrum of damaging alleles any gene is often concentrated on a small number low-frequency variants (0.1% ≤ minor allele frequency < 5%), which survived founding bottleneck, opposed to being distributed over much larger ultra--rare variants. While this advantage well-- established Mendelian genetics, its value common disease genetics has been less explored. FinnGen aims study genome and...

10.1101/2022.03.03.22271360 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2022-03-06
Seyedeh M. Zekavat Shu‐Hong Lin Alexander G. Bick Aoxing Liu Kaavya Paruchuri and 95 more Chen Wang Md Mesbah Uddin Yixuan Ye Zhaolong Yu Xiaoxi Liu Yoichiro Kamatani Romit Bhattacharya James P. Pirruccello Akhil Pampana Po−Ru Loh Puja Kohli Steven A. McCarroll Krzysztof Kiryluk Benjamin M. Neale Iuliana Ionita‐Laza Eric A. Engels Derek W. Brown Jordan W. Smoller Robert C. Green Elizabeth W. Karlson Matthew S. Lebo Patrick T. Ellinor Scott T. Weiss Mark J. Daly Satoshi Koyama Kaoru Ito Yukihide Momozawa Koichi Matsuda Yuji Yamanashi Yoichi Furukawa Takayuki Morisaki Yoshinori Murakami Kaori Muto Akiko Nagai Wataru Obara Ken Yamaji Kazuhisa Takahashi Satoshi Asai Yasuo Takahashi Takao Suzuki Nobuaki Sinozaki Hiroki Yamaguchi Shiro Minami Shigeo Murayama Kozo Yoshimori Satoshi Nagayama Daisuke Obata Masahiko Higashiyama Akihide Masumoto Yukihiro Koretsune Aarno Palotie Adam Ziemann Adele A. Mitchell Adriana Huertas‐Vázquez Aino Salminen Airi Jussila Aki S. Havulinna Alex Mackay Ali Abbasi Amanda Elliott Amy L. Cole Anastasia Shcherban Anders Mälarstig Andrea Ganna Andrey Loboda Anna Podgornaia Anne Lehtonen Anne Pitkäranta Anne M. Remes Annika Auranen Antti Hakanen Antti Palomäki Anu Jalanko Anu Loukola Aparna Chhibber Apinya Lertratanakul Arto Lehistö Graham J. Mann Åsa K. Hedman Audrey Y. Chu Aviv Madar Awaisa Ghazal Benjamin Challis Benjamin B. Sun Beryl B. Cummings Bridget Riley‐Gillis Caroline S. Fox Chia‐Yen Chen Clarence Wang Clément Chatelain Daniel Gordin Danjuma Quarless Danny Oh David F. Choy David A. Close

10.1038/s41591-021-01371-0 article EN Nature Medicine 2021-06-01
Jaakko Tyrmi Tea Kaartokallio A. Inkeri Lokki Tiina Jääskeläinen Eija Kortelainen and 95 more Sanni Ruotsalainen Juha Karjalainen Samuli Ripatti Anna Kivioja Triin Laisk Johannes Kettunen Anneli Pouta Katja Kivinen Eero Kajantie Seppo Heinonen Juha Kere Hannele Laivuori Eeva Ekholm Reija Hietala-Koivu Leea Keski‐Nisula Kaarin Mäkikallio Jukka Uotila Susanna Sainio Terhi Saisto Marja Vääräsmäki Tia Aalto-Viljakainen Leena Georgiadis Jenni Heikkinen‐Eloranta Miira M. Klemetti Sanna Suomalainen‐König Satu Wedenoja Satu Leminen Aija Lähdesmäki Susanna Mehtälä Christina Salmén Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard J. Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Robert M. Plenge Joseph Maranville Mark I. McCarthy Julie Hunkapiller Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O ́Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Juhani Junttila Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia‐Yen Chen Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Xinli Hu Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma ́en Obeidat Johanna Schleutker Mikko Arvas Olli Carpén Reetta Hinttala Graham J. Mann

A genetic contribution to preeclampsia susceptibility has been established but is still incompletely understood.To disentangle the underlying architecture of and or other maternal hypertension during pregnancy with a genome-wide association study (GWAS) hypertensive disorders pregnancy.This GWAS included meta-analyses in combination phenotype encompassing disorders. Two overlapping groups were selected for examination, namely, pregnancy. Data from Finnish Genetics Pre-eclampsia Consortium...

10.1001/jamacardio.2023.1312 article EN cc-by JAMA Cardiology 2023-06-07

Diarrhea is the most frequent health problem among children in developing countries. This study investigated bacterial and viral etiology related clinical epidemiological factors with acute diarrhea Ouagadougou, Burkina Faso. Stool specimens were collected from 283 under 5 years of age visiting hospital due to 60 healthy controls similar age. Pathogens by using conventional culture techniques, PCR immunochromatographic testing. Salmonella Shigella strains serotyped their susceptibility 23...

10.1186/1471-2431-13-36 article EN cc-by BMC Pediatrics 2013-03-19

ObjectivesCarbapenemase-producing Enterobacteriaceae (CPE) are becoming a global problem; they often resistant to nearly all available antibiotics. Here we report details on Finnish CPE isolates found until the end of 2011: carbapenemase genes, travel history and multilocus sequence typing (MLST) data.

10.1093/jac/dks299 article EN Journal of Antimicrobial Chemotherapy 2012-07-31

The Carba NP test was evaluated against a panel of 61 carbapenemase-producing bacterial species (15 producing class A carbapenemases, 15 D and 31 metallo-β-lactamases) 111 isolates with non-wild-type carbapenem susceptibility but not carbapenemase. Carbapenemase production verified by PCR UV-spectrophotometric measurement imipenem hydrolysis. No false positives were seen, there consistent problems the detection OXA-48-like enzymes also some rarer enzymes.

10.1128/aac.02761-13 article EN Antimicrobial Agents and Chemotherapy 2014-09-23
Hanna M. Ollila Eilon Sharon Ling Lin Nasa Sinnott-Armstrong Aditya Ambati and 95 more Selina Yogeshwar Ryan P. Hillary Otto Jolanki Juliette Faraco Mali Einen Guo Luo Jing Zhang Fang Han Han Yan Xiao Song Dong Jing Li Jun Zhang Seung‐Chul Hong Tae Won Kim Yves Dauvilliers Lucie Barateau Gert Jan Lammers Rolf Fronczek Geert Mayer Joan Santamaría Isabelle Arnulf Stine Knudsen May Kristin Lyamouri Bredahl Per Medbøe Thorsby Giuseppe Plazzi Fabio Pizza Monica Moresco Catherine Crowe Stephen K. Van Den Eeden Michel Lecendreux Patrice Bourgin Takashi Kanbayashi F Martínez-Orozco Rosa Peraita‐Adrados Antonio Benetó Jacques Montplaisir Alex Désautels Yu‐Shu Huang Thomas D. Als Adam Ziemann Ali Abbasi Anne Lehtonen Apinya Lertratanakul Bridget Riley‐Gillis Fedik Rahimov Howard J. Jacob Jeffrey F. Waring Mengzhen Liu Nizar Smaoui Relja Popovic Adam Platt Athena Matakidou Benjamin Challis Dirk S. Paul Glenda Lassi Ioanna Tachmazidou Antti Hakanen Johanna Schleutker Nina Pitkänen Perttu Terho Petri Virolainen Arto Mannermaa Veli‐Matti Kosma Chia‐Yen Chen Heiko Runz Sally John Sanni Lahdenperä Stephanie Loomis Susan Eaton George Okafo Heli Salminen‐Mankonen Marc Jung Nathan Lawless Zhihao Ding Joseph Maranville Marla Hochfeld Robert Plenge Shameek Biswas Masahiro Kanai Mutaamba Maasha Wei Zhou Outi Tuovila Raimo Pakkanen Jari A. Laukkanen Teijo Kuopio Kristiina Aittomäki Antti Mäkitie Natalia Pujol Triin Laisk Katriina Aalto‐Setälä Johanna Mäkelä Marco Hautalahti Sarah Smith Tom Southerington Eeva Kangasniemi

Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here, we dissect disease mechanisms interactions environmental triggers in multi-ethnic sample 6,073 cases 84,856 controls. We fine-mapped GWAS signals within HLA (DQ0602, DQB1*03:01 DPB1*04:02) discovered seven novel associations (CD207, NAB1, IKZF4-ERBB3, CTSC, DENND1B, SIRPG, PRF1). Significant at TRA DQB1*06:02 loci...

10.1038/s41467-023-36120-z article EN cc-by Nature Communications 2023-05-15
Nina Mars Sini Kerminen Max Tamlander Matti Pirinen Eveliina Jakkula and 95 more Kirsimari Aaltonen Tuomo J Meretoja Sirpa Heinävaara Elisabeth Widén Samuli Ripatti Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Robert M. Plenge Joseph Maranville Mark I. McCarthy Julie Hunkapiller Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O’Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Juhani Junttila Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia‐Yen Chen Heiko Runz Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass Julie Hunkapiller Margaret G. Ehm David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Anders Mälarstig Xinli Hu K. Klinger Robert Graham Eric Green Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma’en Obeidat Samuli Ripatti Johanna Schleutker Markus Perola Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Graham J. Mann Katriina Aalto‐Setälä Mika Kähönen Jari A. Laukkanen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Minna Raivio Pentti Tienari Juha O. Rinne Roosa Kallionpää Juulia Partanen

PURPOSE Family history (FH) and pathogenic variants (PVs) are used for guiding risk surveillance in selected high-risk women but little is known about their impact breast cancer screening on population level. In addition, polygenic scores (PRSs) have been shown to efficiently stratify through combining information common genetic factors into one measure. METHODS longitudinal real-life data, we evaluate PRS, FH, PVs stratified screening. Using FinnGen (N = 117,252), linked the Mass Screening...

10.1200/jco.23.00295 article EN cc-by-nc-nd Journal of Clinical Oncology 2024-02-29

ABSTRACT We evaluated 1,010 Salmonella isolates classified as fluoroquinolone susceptible according to the National Committee for Clinical Laboratory Standards guidelines susceptibility nalidixic acid and three fluoroquinolones. These were divided into two distinct subpopulations, with great majority ( n = 960) being fully ciprofloxacin a minority 50) exhibiting reduced (MICs ranging between 0.125 0.5 μg/ml). The less ciprofloxacin-susceptible uniformly resistant acid, while only 12 (1.3%)...

10.1128/jcm.37.11.3572-3577.1999 article EN Journal of Clinical Microbiology 1999-11-01
Max Tamlander Nina Mars Matti Pirinen Aarno Palotie Mark J. Daly and 95 more Bridget Riley-Gills Howard J. Jacob Dirk S. Paul Heiko Runz Sally John Robert M. Plenge Joseph Maranville George Okafo Nathan Lawless Heli Salminen‐Mankonen Mark I. McCarthy Julie Hunkapiller Meg Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig Katherine Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O’Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Juhani Junttila Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Arto Mannermaa Jari Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey Waring Ioanna Tachmazidou Chia-Yen Chen Shameek Biswas Zhihao Ding Marc Jung Rion Pendergrass David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Xinli Hu Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma ́en Obeidat Samuli Ripatti Johanna Schleutker Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Katriina Aalto‐Setälä Mika Kähönen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Pentti J. Tienari Juha O. Rinne Roosa Kallionpää Ali Abbasi Adam Ziemann Sahar Esmaeeli Nizar Smaoui Anne Lehtonen Susan Eaton Sanni Lahdenperä Janet van Adelsberg Natalie Bowers Edmond Teng Sarah A. Pendergrass Onuralp Söylemez Kari Linden Fanli Xu Laura Addis John D. Eicher Minna Raivio Beryl B. Cummings Juulia Partanen Martti Färkkilâ Jukka Koskela

Abstract Large-scale biobank initiatives and commercial repositories store genomic data collected from millions of individuals, tools to leverage the rapidly growing pool health in disease prevention are needed. Here, we describe derivation validation genomics-enhanced risk for two common cardiometabolic diseases, coronary heart type 2 diabetes. Data used our analyses include FinnGen study (N = 309,154) UK Biobank project 343,672). The integrate contemporary genome-wide polygenic scores with...

10.1038/s42003-021-02996-0 article EN cc-by Communications Biology 2022-02-23
Samuel E. Jones Fahrisa I. Maisha Satu Strausz Vilma Lammi Brian E. Cade and 95 more Anniina Tervi Viola Helaakoski Martin Broberg Aarno Palotie Mark Daly Bridget Riley-Gills Howard Jacob Dirk S. Paul Slavé Petrovski Heiko Runz Sally John George Okafo Nathan Lawless Heli Salminen‐Mankonen Robert Plenge Joseph Maranville Mark I. McCarthy Margaret G. Ehm Kirsi Auro Simonne Longerich Anders Mälarstig Katherine Klinger Clément Chatelain Matthias Gossel Karol Estrada Robert Graham Robert Yang Chris O ́Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Taneli Raivio Jani T. Tikkanen Raisa Serpi Tarja Laitinen Veli-Matti Kosma Jari Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey Waring Bridget Riley-Gillis Fedik Rahimov Ioanna Tachmazidou Chia-Yen Chen Heiko Runz Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass Margaret G. Ehm David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Anders Mälarstig Xinli Hu Åsa K. Hedman Katherine Klinger Robert Graham Manuel Rivas Dawn Waterworth Nicole Renaud Ma ́en Obeidat Samuli Ripatti Johanna Schleutker Markus Perola Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Arto Mannermaa Katriina Aalto‐Setälä Mika Kähönen Jari Laukkanen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Minna Raivio Pentti Tienari Juha O. Rinne Roosa Kallionpää Juulia Partanen Ali Abbasi Adam Ziemann Nizar Smaoui

BackgroundPoor sleep is associated with an increased risk of infections and all-cause mortality but the causal direction between poor respiratory has remained unclear. We examined if contributes as a factor to infections.MethodsWe used data on insomnia, influenza upper (URIs) from primary care hospital records in UK Biobank (N ≈ 231,000) FinnGen 392,000). computed logistic regression assess association infections, disease free survival hazard ratios, performed Mendelian randomization...

10.1016/j.ebiom.2023.104630 article EN cc-by-nc-nd EBioMedicine 2023-06-08
Eliza C. Miller Anni Kauko Sarah E. Tom Hannele Laivuori Teemu Niiranen and 95 more Natalie A. Bello Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard J. Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Heli Salminen‐Mankonen Robert Plenge Joseph Maranville Mark I. McCarthy Julie Hunkapiller Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O ́Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Taneli Raivio Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia-Yen Chen Heiko Runz Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass Julie Hunkapiller Margaret G. Ehm David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Anders Mälarstig Xinli Hu K. Klinger Robert Graham Eric Green Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma ́en Obeidat Samuli Ripatti Johanna Schleutker Markus Perola Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Graham J. Mann Katriina Aalto‐Setälä Mika Kähönen Jari A. Laukkanen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Minna Raivio Pentti J. Tienari Juha O. Rinne Roosa Kallionpää Juulia Partanen Ali Abbasi Adam Ziemann Nizar Smaoui

BACKGROUND: Adverse pregnancy outcomes (APO) contribute to higher risk of maternal cerebrovascular disease, but longitudinal data that include APO and stroke timing are lacking. We hypothesized associated with younger age at first stroke, a stronger relationship in those >1 APO. METHODS: analyzed Finnish nationwide health registry from the FinnGen Study. included women who gave birth after 1969 when hospital discharge was established. defined as affected by gestational hypertension,...

10.1161/strokeaha.123.043052 article EN Stroke 2023-05-22

During 1995 to 1999, we collected 1,210 Salmonella isolates; 629 were from Finnish travelers returning abroad. These isolates tested for susceptibility by determining MICs ciprofloxacin, nalidixic acid, and seven additional antimicrobial agents. From the annual proportion of reduced ciprofloxacin (MIC > 0.125 microg/mL) among all travelers' increased 3.9% 23.5% (p<0.001). The increasing trend was outstanding Southeast Asia; Thailand alone 5.6% 50.0% fluoroquinolone nonclonal in character...

10.3201/eid0706.010613 article EN Emerging infectious diseases 2001-12-01

ABSTRACT Enterobacteria in fecal flora are often reported to be highly resistant. Escherichia coli is the main species; resistance data on other species rare. To assess effect of host's environment, antimicrobial was determined family Enterobacteriaceae from three populations: healthy people (HP)( n = 125) with no exposure antimicrobials for 3 months preceding sampling, university hospital patients (UP) ( 159) wards where antibiotic use 112 defined daily doses (DDD)/bed/month, and geriatric...

10.1128/aac.44.6.1479-1484.2000 article EN cc-by Antimicrobial Agents and Chemotherapy 2000-06-01

ABSTRACT There is a paucity of information regarding antimicrobial agents that are suitable to treat severe infections caused by multidrug-resistant Campylobacter spp. Our aim was identify potentially effective against multiresistant strains. The in vitro activities 20 238 strains were analyzed determining MICs the agar plate dilution method or Etest. These selected from 1,808 isolates collected Finnish patients between 2003 and 2005 screened for macrolide susceptibility using disk diffusion...

10.1128/aac.00898-09 article EN Antimicrobial Agents and Chemotherapy 2009-12-29

Objectives The common cold is the main cause of medical time loss in elite sport. Rapid diagnosis has been a challenge that may be amenable to molecular point-of-care testing (POCT). Methods We performed prospective observational study Team Finland during 2018 Winter Olympic Games. There were 44 athletes and 68 staff members. chief physician recorded symptoms daily on standardised form. Two nasal swabs taken at onset symptoms. One swab was analysed within 45 min using POCT for respiratory...

10.1136/bjsports-2018-100487 article EN cc-by-nc British Journal of Sports Medicine 2019-05-29
Eeva Sliz Jaakko Tyrmi Nilüfer Rahmioğlu Krina T. Zondervan Christian M. Becker and 95 more Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Heli Salminen‐Mankonen Robert Plenge Joseph Maranville Mark I. McCarthy Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Clément Chatelain Matthias Gossel Karol Estrada Robert Graham Robert Yang Chris O ́Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Taneli Raivio Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia‐Yen Chen Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Xinli Hu Åsa K. Hedman Manuel A. Rivas Dawn Waterworth Nicole Renaud Ma ́en Obeidat Samuli Ripatti Johanna Schleutker Mikko Arvas Olli Carpén Reetta Hinttala Arto Mannermaa Katriina Aalto‐Setälä Mika Kähönen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Minna Raivio Pentti Tienari Juha O. Rinne Roosa Kallionpää Juulia Partanen Ali Abbasi Adam Ziemann Nizar Smaoui Anne Lehtonen Susan Eaton Sanni Lahdenperä Natalie Bowers Edmond Teng Fanli Xu Laura Addis John D. Eicher Qingqin S. Li Karen He

Uterine leiomyomata (UL) are the most common tumours of female genital tract and primary cause surgical removal uterus. Genetic factors contribute to UL susceptibility. To add understanding heritable genetic risk factors, we conduct a genome-wide association study (GWAS) in up 426,558 European women from FinnGen previous meta-GWAS. In addition 50 known loci, identify 22 loci that have not been associated with prior studies. UL-associated harbour genes enriched for development, growth,...

10.1038/s41467-023-35974-7 article EN cc-by Nature Communications 2023-02-01

Although prostate cancer (PCa) is the most common in men Western countries, there significant variability geographical incidence. This might result from genetic factors, discrepancies screening policies, or differences lifestyle. Gut microbiota has recently been associated with progression, but its role PCa unclear. Characterization of gut and functions PCa. In a prospective multicenter clinical trial (NCT02241122), profiles 181 suspicion were assessed utilizing 16S rRNA sequencing....

10.1016/j.euros.2024.02.004 article EN cc-by European Urology Open Science 2024-03-13

Abstract Ciprofloxacin resistance was analyzed in 354 Campylobacter jejuni isolates collected during two study periods (1995–1997 and 1998–2000) from travelers returning to Finland. The increase between the significant among all (40% vs. 60%; p<0.01), as well those Asia alone (45% 72%; p<0.01).

10.3201/eid0902.020227 article EN cc-by Emerging infectious diseases 2003-02-01

Objectives: The resistance of Campylobacter jejuni to fluoroquinolones is increasing globally. This study was performed delineate those antimicrobial agents that are effective in vitro against ciprofloxacin-resistant C. isolates and potentially suitable for the treatment severe disease when fluoroquinolone or multidrug known suspected.

10.1093/jac/dkg489 article EN Journal of Antimicrobial Chemotherapy 2003-11-12

During a 9-year study period from 1997 through 2005, the association between antimicrobial resistance rates in Escherichia coli and outpatient consumption was investigated 20 hospital districts Finland. A total of 754,293 E. isolates, mainly urine samples, were tested for 26 clinical microbiology laboratories. The following antimicrobials studied: ampicillin, amoxicillin-clavulanate, cephalosporins, fluoroquinolones, trimethoprim, trimethoprim-sulfamethoxazole, pivmecillinam, nitrofurantoin....

10.1128/aac.00856-08 article EN Antimicrobial Agents and Chemotherapy 2008-12-23

Nontyphoidal Salmonella enterica strains with a nonclassical quinolone resistance phenotype were isolated from patients returning Thailand or Malaysia to Finland. A total of 10 isolates seven serovars studied in detail, all which had reduced susceptibility (MIC > = 0.125 microg/ml) ciprofloxacin but either susceptible showed only low-level < 32 nalidixic acid. Phenotypic characterization included testing by the agar dilution method and investigation efflux activity. Genotypic screening...

10.1128/aac.00121-09 article EN Antimicrobial Agents and Chemotherapy 2009-07-14

The agar dilution method has been standardized by the CLSI for susceptibility testing of Campylobacter species, and according to these standards, disk diffusion should be used only in screening macrolide ciprofloxacin resistance. Nevertheless, test is currently widely used, since it easy perform clinical microbiology laboratories. In this study, was compared analyzing vitro activities seven antimicrobial agents against 174 strains collected Finland between 2003 2008. Recommendations were...

10.1128/jcm.01090-11 article EN Journal of Clinical Microbiology 2011-11-11
Coming Soon ...